Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Mol Cancer Ther. 2021 Apr;20(4):625–631. doi: 10.1158/1535-7163.MCT-20-0738

Figure 1.

Figure 1.

Chemical structures of cytidine analogs which are FDA-approved drugs, cytatabine, azacytidine, decitabine, and gemcitabine, and investigational agents, 4’-thio-2’-deoxycytidine (T-dCyd), 5-aza-4’-thio-2’-deoxycytidine (aza-T-dCyd), and fluorine containing cytidine compounds, RX-3117 F-T-dCyd (FF-10502) and F-aza-T-dCyd (NSC801845).